InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Cohen Chad M, Chief Financial Officer. Insider active across 3 companies, notably Adaptive Biotechnologies Corp. Cumulatively, 18 reports have been logged. History available since 11 May 2021. The latest transaction was filed on 2 June 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Cohen Chad M
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
13,593 shares0Common StockSEC:0001524314-26-000001:0
4,049 shares0Common StockSEC:0001524314-26-000001:1
221 shares0Common StockSEC:0001524314-25-000004:0
9,336 shares0Common StockSEC:0001415889-25-022836:0
9,336 shares0Common StockSEC:0001415889-25-020856:0
1,397 shares0Common StockSEC:0001415889-25-015819:0
8,158 sharesClass A Common StockSEC:0001140361-25-016925:0
20,134 shares0Class A Common StockSEC:0001874944-24-000062:0
170,940 shares0Class A Common StockSEC:0001874944-23-000053:0
33,999 shares0Class A Common StockSEC:0001874944-22-000028:0
10,000 shares@ US$7.2717.4% of flowCommon StockSEC:0001209191-21-071193:0
5,000 shares@ US$7.278.5% of flowCommon StockSEC:0001209191-21-064253:0
5,000 shares@ US$7.278.5% of flowCommon StockSEC:0001209191-21-059985:0
9,375 shares@ US$6.5514.0% of flowCommon StockSEC:0001209191-21-055368:0
5,000 shares@ US$6.557.5% of flowCommon StockSEC:0001209191-21-051275:0
10,000 shares@ US$6.5515.0% of flowCommon StockSEC:0001209191-21-046082:0
10,000 shares@ US$6.5514.5% of flowCommon StockSEC:0001209191-21-039637:0
10,000 shares@ US$6.5514.6% of flowCommon StockSEC:0001209191-21-032438:0
18 of 18 declarations
About Cohen Chad M
Chad M. Cohen is a Chief Financial Officer. He has 18 filings in total, and across the 18 recent filings available, the transactions are Attribution, with buy and sell amounts of EUR 0; the observed period runs from 2021-05-13 to 2026-06-04. The recent filings concern Adaptive Biotechnologies Corp, where he is Chief Financial Officer, as well as Grindr Inc. and Vacasa, Inc., where he is Director.
